DRF 2519 is a dual activator of PPAR-alpha and PPAR-gamma. DRF 2519 is a potential candidate in the management of metabolic disorders and associated complications. References: Chakrabarti R, Misra P, Vikramadithyan RK, Premkumar M, Hiriyan J, Datla SR, Damarla RK, Suresh J, Rajagopalan R. Antidiabetic and hypolipidemic potential of DRF 2519--a dual activator of PPAR-alpha and PPAR-gamma. Eur J Pharmacol. 2004 May 3;491(2-3):195-206. PubMed PMID: 15140637.

纯度：≥98%

CAS：194713-46-7